EDGAR Filing Documents for 0001104659-15-064414

Form 8-K - Current report:

SEC Accession No. 0001104659-15-064414

Filing Date

2015-09-10

Accepted

2015-09-10 06:03:58

Documents

Period of Report

2015-09-08

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a15-19155_18k.htm	8-K	23259
2	EX-99.1	a15-19155_1ex99d1.htm	EX-99.1	20902
3	GRAPHIC	g191551mmi001.gif	GRAPHIC	3807
	Complete submission text file	0001104659-15-064414.txt		50801

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054

Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560

Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 151099971
SIC: 2834 Pharmaceutical Preparations